- Factor advances next-generation allogeneic and in vivo CAR-T cell therapy programs
- Presentations will include latest data from Factor’s IL12-expressing iMacrophages for treating solid tumors (FACT-112), as well as recent advances in Factor’s RNA-based cell reprogramming technologies
- Factor to reveal two novel iPSC-derived mesenchymal stem cell (iMSC) programs: Hypoimmune iMSCs for muscular dystrophy and HTRA1-expressing iMSCs for neurodegenerative disorders
Cord Blood Industry Consolidation Escalates in 2026
The global cord blood industry experienced strong growth from the early 1990’s through the late 2000’s, during which time more than 450 cord blood banking companies emerged worldwide. Approximately half of those companies owned their own labs, while the others were marketing entities or sub-contractors of storage space.
Starting about ten years ago, the market suddenly changed course. It entered a period of aggressive consolidation, cutting the global number of cord blood banks by approximately half.
Over the past decade, the cord blood industry has witnessed substantial consolidation, particularly within the United States, Europe, Asia, and Latin America. [Read more…]
How Induced Pluripotent Stem Cells (iPSCs) Are Changing The World As We Know It
Since their introduction in 2006, iPSCs (or induced pluripotent stem cells) have changed the way we research and treat diseases. In large part, this is thanks to bypassing the ethical concerns associated with embryonic stem cells.
So, why exactly is everyone talking about iPSC applications and their uses within medicine?
If you’re interested in the answer, we’ve made this guide to highlight the ways these stem cells are impacting a wide variety of industries. Let’s get started. [Read more…]
Pivotal Trends Impacting the Global Cord Blood and Tissue Industry in 2026
The cord blood industry came into existence in the early 1990’s with the formation of several cord blood banks in the U.S. and worldwide. It has been 40 years since it was first proposed that stem and progenitor cells were present in human cord blood. [Read more…]
10 Biotherapies Books From AABB To Add To Your Reading List In 2026
There is no better time to put together your biotherapies reading list for 2026! In partnership with AABB (Association for the Advancement of Blood &Â Biotherapies), BioInformant shares 10 must-have technical resources and guides for biotherapies enthusiasts. [Read more…]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 202
- Next Page »